BidaskClub upgraded shares of PetIQ (NASDAQ:PETQ) from a hold rating to a buy rating in a report released on Friday, BidAskClub reports.

A number of other analysts also recently issued reports on the stock. Oppenheimer restated a buy rating on shares of PetIQ in a report on Friday, May 8th. Raymond James raised their price target on shares of PetIQ from $32.00 to $35.00 and gave the stock an outperform rating in a report on Tuesday, June 16th. SunTrust Banks raised their price target on shares of PetIQ from $30.00 to $35.00 and gave the stock a buy rating in a report on Friday, May 8th. Guggenheim lifted their target price on shares of PetIQ from $33.50 to $44.00 and gave the company a buy rating in a report on Thursday, June 25th. They noted that the move was a valuation call. Finally, Zacks Investment Research downgraded shares of PetIQ from a buy rating to a hold rating in a report on Tuesday, May 12th. Two analysts have rated the stock with a hold rating and five have issued a buy rating to the company. PetIQ currently has an average rating of Buy and a consensus target price of $36.50.

Shares of NASDAQ PETQ opened at $33.86 on Friday. The company has a 50 day simple moving average of $29.88 and a 200-day simple moving average of $27.52. The company has a market capitalization of $971.73 million, a P/E ratio of -52.09, a P/E/G ratio of 1.29 and a beta of 1.68. The company has a debt-to-equity ratio of 1.04, a current ratio of 2.85 and a quick ratio of 1.67. PetIQ has a 1 year low of $15.83 and a 1 year high of $36.33.

PetIQ (NASDAQ:PETQ) last announced its quarterly earnings results on Thursday, May 7th. The company reported $0.19 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.17 by $0.02. The business had revenue of $186.78 million during the quarter, compared to the consensus estimate of $176.52 million. PetIQ had a negative net margin of 2.03% and a positive return on equity of 8.28%. As a group, research analysts expect that PetIQ will post 1.06 EPS for the current year.

In related news, Director Will Santana sold 17,500 shares of PetIQ stock in a transaction that occurred on Tuesday, June 16th. The shares were sold at an average price of $31.43, for a total value of $550,025.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders sold a total of 76,667 shares of company stock valued at $2,388,649 in the last quarter. 24.12% of the stock is owned by insiders.

Institutional investors have recently bought and sold shares of the stock. Great West Life Assurance Co. Can purchased a new position in PetIQ in the 4th quarter valued at approximately $31,000. Toth Financial Advisory Corp purchased a new position in PetIQ in the 1st quarter valued at approximately $40,000. Banque Cantonale Vaudoise purchased a new position in PetIQ in the 4th quarter valued at approximately $82,000. Advisor Group Inc. boosted its position in PetIQ by 8.6% in the 4th quarter. Advisor Group Inc. now owns 5,105 shares of the company’s stock valued at $128,000 after buying an additional 405 shares during the period. Finally, Citigroup Inc. boosted its position in PetIQ by 155.7% in the 4th quarter. Citigroup Inc. now owns 5,917 shares of the company’s stock valued at $148,000 after buying an additional 3,603 shares during the period. Hedge funds and other institutional investors own 94.75% of the company’s stock.

About PetIQ

PetIQ, Inc operates as a pet health and wellness company. It operates through two segments, Products and Services. It manufactures and distributes veterinarian services and veterinarian-grade pet products, including prescription (Rx) medications, over-the-counter (OTC) flea and tick preventatives, and health and wellness products for dogs and cats.

See Also: Terms to Better Understand Call Options

Receive News & Ratings for PetIQ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetIQ and related companies with MarketBeat.com's FREE daily email newsletter.